<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunopathology Quiz | Chapter 7</title>
    <link rel="stylesheet" href="style.css">
    <style>
        /* style.css - Universal quiz styling */
:root {
    --primary: #3498db;
    --secondary: #2c3e50;
    --success: #2ecc71;
    --danger: #e74c3c;
    --warning: #f39c12;
    --light: #ecf0f1;
    --dark: #34495e;
    --shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
    --transition: all 0.3s ease;
}

* {
    margin: 0;
    padding: 0;
    box-sizing: border-box;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
}

body {
    background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
    color: var(--dark);
    line-height: 1.6;
    min-height: 100vh;
    padding: 20px;
}

.container {
    max-width: 1000px;
    margin: 0 auto;
    background-color: white;
    border-radius: 15px;
    box-shadow: var(--shadow);
    overflow: hidden;
}

header {
    background: linear-gradient(to right, var(--primary), var(--secondary));
    color: white;
    padding: 25px;
    text-align: center;
}

header h1 {
    font-size: 2.2rem;
    margin-bottom: 10px;
}

header p {
    font-size: 1.1rem;
    opacity: 0.9;
}

.quiz-info {
    display: flex;
    justify-content: space-between;
    padding: 15px 25px;
    background-color: var(--light);
    border-bottom: 1px solid #ddd;
}

.timer {
    font-size: 1.2rem;
    font-weight: bold;
    color: var(--danger);
}

.progress {
    display: flex;
    align-items: center;
    gap: 10px;
}

.progress-bar {
    width: 200px;
    height: 10px;
    background-color: #ddd;
    border-radius: 5px;
    overflow: hidden;
}

.progress-fill {
    height: 100%;
    background-color: var(--primary);
    width: 0%;
    transition: var(--transition);
}

.quiz-container {
    padding: 30px;
}

.question-container {
    margin-bottom: 30px;
}

.question-number {
    font-size: 1.1rem;
    color: var(--primary);
    margin-bottom: 5px;
}

.question-text {
    font-size: 1.4rem;
    font-weight: 600;
    margin-bottom: 20px;
    line-height: 1.4;
}

.options-container {
    display: grid;
    gap: 12px;
    margin-bottom: 25px;
}

.option {
    padding: 15px;
    background-color: var(--light);
    border-radius: 8px;
    cursor: pointer;
    transition: var(--transition);
    border: 2px solid transparent;
}

.option:hover {
    background-color: #e0e7ee;
    transform: translateY(-2px);
}

.option.selected {
    border-color: var(--primary);
    background-color: rgba(52, 152, 219, 0.1);
}

.option.correct {
    border-color: var(--success);
    background-color: rgba(46, 204, 113, 0.1);
}

.option.incorrect {
    border-color: var(--danger);
    background-color: rgba(231, 76, 60, 0.1);
}

.explanation-container {
    padding: 20px;
    background-color: rgba(52, 152, 219, 0.05);
    border-radius: 8px;
    margin-bottom: 20px;
    display: none;
}

.explanation-title {
    font-weight: 600;
    color: var(--primary);
    margin-bottom: 10px;
}

.memory-tip {
    background-color: rgba(243, 156, 18, 0.1);
    padding: 15px;
    border-left: 4px solid var(--warning);
    margin-top: 15px;
    border-radius: 0 8px 8px 0;
}

.memory-tip-title {
    font-weight: 600;
    color: var(--warning);
    margin-bottom: 5px;
}

.navigation {
    display: flex;
    justify-content: space-between;
    margin-top: 20px;
}

button {
    padding: 12px 25px;
    border: none;
    border-radius: 8px;
    font-weight: 600;
    cursor: pointer;
    transition: var(--transition);
}

.btn-prev {
    background-color: var(--light);
    color: var(--dark);
}

.btn-next {
    background-color: var(--primary);
    color: white;
}

.btn-submit {
    background-color: var(--success);
    color: white;
    display: none;
}

button:hover {
    transform: translateY(-2px);
    box-shadow: var(--shadow);
}

button:disabled {
    opacity: 0.6;
    cursor: not-allowed;
    transform: none;
    box-shadow: none;
}

.results-container {
    padding: 30px;
    text-align: center;
    display: none;
}

.results-title {
    font-size: 2rem;
    margin-bottom: 20px;
    color: var(--secondary);
}

.score {
    font-size: 4rem;
    font-weight: bold;
    color: var(--primary);
    margin: 20px 0;
}

.score-text {
    font-size: 1.3rem;
    margin-bottom: 30px;
}

.summary {
    text-align: left;
    background-color: var(--light);
    padding: 20px;
    border-radius: 8px;
    margin-top: 20px;
}

.summary-title {
    font-weight: 600;
    margin-bottom: 10px;
    color: var(--secondary);
}

.restart-btn {
    background-color: var(--primary);
    color: white;
    margin-top: 20px;
    padding: 15px 30px;
    font-size: 1.1rem;
}

.question-review {
    margin-top: 30px;
    text-align: left;
}

.review-item {
    margin-bottom: 20px;
    padding-bottom: 20px;
    border-bottom: 1px solid #ddd;
}

.review-question {
    font-weight: 600;
    margin-bottom: 10px;
}

.review-answer {
    margin-bottom: 5px;
}

.correct-answer {
    color: var(--success);
    font-weight: 600;
}

.user-answer {
    color: var(--danger);
    font-weight: 600;
}

@media (max-width: 768px) {
    .quiz-info {
        flex-direction: column;
        gap: 15px;
        text-align: center;
    }

    .progress-bar {
        width: 100%;
    }

    .question-text {
        font-size: 1.2rem;
    }

    .navigation {
        flex-direction: column;
        gap: 10px;
    }

    button {
        width: 100%;
    }
}

/* Welcome page styling */
.welcome-container {
    padding: 40px;
    text-align: center;
}

.quiz-selection {
    display: grid;
    grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
    gap: 20px;
    margin: 40px 0;
}

.quiz-card {
    background: white;
    border-radius: 10px;
    padding: 25px;
    box-shadow: var(--shadow);
    transition: var(--transition);
    border: 2px solid transparent;
}

.quiz-card:hover {
    transform: translateY(-5px);
    border-color: var(--primary);
}

.quiz-card h3 {
    color: var(--secondary);
    margin-bottom: 15px;
}

.quiz-card p {
    margin-bottom: 20px;
    color: #666;
}

.quiz-meta {
    display: flex;
    justify-content: space-between;
    margin-top: 15px;
    font-size: 0.9rem;
    color: var(--dark);
}

.btn-start {
    background-color: var(--primary);
    color: white;
    margin-top: 15px;
    width: 100%;
}

.back-btn {
    background-color: var(--light);
    color: var(--dark);
    margin-top: 20px;
}
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Chapter 7: Immunopathology Quiz</h1>
            <p>General Pathology | Health Science Students</p>
        </header>

        <div class="quiz-info">
            <div class="timer">Time: <span id="time">65:00</span></div>
            <div class="progress">
                <span>Progress:</span>
                <div class="progress-bar">
                    <div class="progress-fill" id="progress-fill"></div>
                </div>
                <span id="progress-text">0/65</span>
            </div>
        </div>

        <div class="quiz-container" id="quiz-container">
            <div class="question-container">
                <div class="question-number" id="question-number">Question 1 of 65</div>
                <div class="question-text" id="question-text"></div>
                <div class="options-container" id="options-container"></div>
            </div>

            <div class="explanation-container" id="explanation-container">
                <div class="explanation-title">Explanation</div>
                <div id="explanation-text"></div>
                <div class="memory-tip" id="memory-tip">
                    <div class="memory-tip-title">Memory Tip</div>
                    <div id="memory-tip-text"></div>
                </div>
            </div>

            <div class="navigation">
                <button class="btn-prev" id="prev-btn" disabled>Previous</button>
                <button class="btn-next" id="next-btn">Next Question</button>
                <button class="btn-submit" id="submit-btn">Submit Quiz</button>
            </div>
        </div>

        <div class="results-container" id="results-container">
            <h2 class="results-title">Quiz Results</h2>
            <div class="score" id="score">0/65</div>
            <div class="score-text" id="score-text"></div>

            <div class="summary">
                <div class="summary-title">Performance Summary</div>
                <p>Total Questions: <span id="total-questions">65</span></p>
                <p>Correct Answers: <span id="correct-answers">0</span></p>
                <p>Incorrect Answers: <span id="incorrect-answers">0</span></p>
                <p>Percentage: <span id="percentage">0%</span></p>
                <p>Time Taken: <span id="time-taken">65:00</span></p>
            </div>

            <div class="question-review" id="question-review">
                <h3>Question Review</h3>
                <!-- Review content will be generated by JavaScript -->
            </div>

            <button class="restart-btn" id="restart-btn">Restart Quiz</button>
        </div>
    </div>

    <script>
        // Immunopathology Chapter 7 Questions (65 questions)
        const questions = [
            {
                question: "According to Gell and Coombs classification, how many types of hypersensitivity reactions are there?",
                options: [
                    "Two types",
                    "Three types",
                    "Four types",
                    "Five types"
                ],
                correct: 2,
                explanation: "Hypersensitivity reactions are classified into four types (I, II, III, and IV) based on the mechanism of immune recognition and inflammatory mediators involved.",
                memoryTip: "Gell and Coombs = 4 types of hypersensitivity (I-IV)."
            },
            {
                question: "Which type of hypersensitivity reaction is mediated by IgE antibodies bound to mast cells?",
                options: [
                    "Type I",
                    "Type II",
                    "Type III",
                    "Type IV"
                ],
                correct: 0,
                explanation: "Type I hypersensitivity (anaphylactic/immediate) involves IgE antibodies bound to mast cells or basophils, leading to rapid degranulation upon antigen exposure.",
                memoryTip: "Type I = Immediate, IgE, Mast cells."
            },
            {
                question: "Which cells are central to the development of Type I hypersensitivity reactions?",
                options: [
                    "Neutrophils and macrophages",
                    "Mast cells and basophils",
                    "T-lymphocytes only",
                    "Eosinophils only"
                ],
                correct: 1,
                explanation: "Mast cells and basophils armed with cytophilic IgE antibodies are central to Type I reactions, releasing preformed and newly synthesized mediators upon antigen exposure.",
                memoryTip: "Type I: Mast cells & Basophils = KEY players."
            },
            {
                question: "Which mediator is responsible for the late phase of Type I hypersensitivity reactions?",
                options: [
                    "Histamine only",
                    "Leukotrienes and cytokines",
                    "IgG antibodies",
                    "Complement proteins"
                ],
                correct: 1,
                explanation: "The late phase (4-8 hours after exposure) is mediated by leukotrienes, platelet-activating factor, TNF-α, and cytokines that recruit eosinophils, neutrophils, and monocytes.",
                memoryTip: "Late phase = Leukotrienes, Cytokines, Cell recruitment."
            },
            {
                question: "What is the prototype example of Type I hypersensitivity in the respiratory tract?",
                options: [
                    "Rheumatoid arthritis",
                    "Bronchial asthma",
                    "Systemic lupus erythematosus",
                    "Myasthenia gravis"
                ],
                correct: 1,
                explanation: "Bronchial asthma is a classic example of Type I hypersensitivity affecting the respiratory tract, characterized by bronchoconstriction, edema, and mucus secretion.",
                memoryTip: "Asthma = Type I hypersensitivity in lungs."
            },
            {
                question: "Which type of hypersensitivity involves antibody-mediated cellular dysfunction without causing cell injury?",
                options: [
                    "Type I",
                    "Type II",
                    "Type III",
                    "Type IV"
                ],
                correct: 1,
                explanation: "Type II hypersensitivity includes antibody-mediated cellular dysfunction where antibodies against cell surface receptors impair function without inflammation (e.g., myasthenia gravis).",
                memoryTip: "Type II = Antibodies against receptors → dysfunction."
            },
            {
                question: "In Type II hypersensitivity, what mechanism involves complement-mediated lysis of target cells?",
                options: [
                    "Antibody-dependent cell-mediated cytotoxicity (ADCC)",
                    "Opsonization by C3b",
                    "Direct lysis by membrane attack complex (C5-9)",
                    "Cellular dysfunction without injury"
                ],
                correct: 2,
                explanation: "Complement-dependent direct lysis occurs when antibodies bind to cell surface antigens, activating complement and forming membrane attack complex (C5-9) that disrupts cell membranes.",
                memoryTip: "Type II: Complement MAC (C5-9) → cell lysis."
            },
            {
                question: "Which disease is an example of Type II hypersensitivity involving antibody-mediated cellular dysfunction?",
                options: [
                    "Systemic lupus erythematosus",
                    "Graves disease",
                    "Tuberculin reaction",
                    "Serum sickness"
                ],
                correct: 1,
                explanation: "Graves disease involves antibodies against TSH receptors that stimulate thyroid cells (cellular dysfunction), a Type II hypersensitivity mechanism.",
                memoryTip: "Graves disease = Type II, anti-TSH receptor antibodies."
            },
            {
                question: "What is the primary mechanism of tissue injury in Type III hypersensitivity?",
                options: [
                    "Direct T-cell cytotoxicity",
                    "Immune complex deposition and complement activation",
                    "IgE-mediated mast cell degranulation",
                    "Antibody-mediated phagocytosis"
                ],
                correct: 1,
                explanation: "Type III hypersensitivity involves antigen-antibody complex deposition in tissues, leading to complement activation, neutrophil recruitment, and inflammatory tissue damage.",
                memoryTip: "Type III = Immune complexes + Complement → inflammation."
            },
            {
                question: "Which of the following is a systemic immune complex disease?",
                options: [
                    "Arthus reaction",
                    "Serum sickness",
                    "Contact dermatitis",
                    "Tuberculin reaction"
                ],
                correct: 1,
                explanation: "Serum sickness is a systemic immune complex disease resulting from circulating antigen-antibody complexes depositing in multiple tissues (e.g., blood vessels, kidneys, joints).",
                memoryTip: "Serum sickness = Systemic Type III hypersensitivity."
            },
            {
                question: "What is the Arthus reaction?",
                options: [
                    "A localized Type III hypersensitivity in skin",
                    "A systemic Type I reaction",
                    "A Type IV reaction to tuberculin",
                    "An antibody deficiency disorder"
                ],
                correct: 0,
                explanation: "The Arthus reaction is a localized Type III hypersensitivity (immune complex vasculitis) in the skin, occurring 4-8 hours after antigen inoculation in sensitized individuals.",
                memoryTip: "Arthus reaction = Local skin Type III (immune complex vasculitis)."
            },
            {
                question: "Which type of hypersensitivity is also called delayed-type hypersensitivity?",
                options: [
                    "Type I",
                    "Type II",
                    "Type III",
                    "Type IV"
                ],
                correct: 3,
                explanation: "Type IV hypersensitivity is cell-mediated and delayed (24-72 hours), involving sensitized T-lymphocytes rather than antibodies.",
                memoryTip: "Type IV = Delayed, T-cell mediated."
            },
            {
                question: "What is the typical time frame for a Type IV hypersensitivity reaction to manifest?",
                options: [
                    "Within minutes",
                    "4-8 hours",
                    "24-72 hours",
                    "1 week"
                ],
                correct: 2,
                explanation: "Type IV (delayed-type) hypersensitivity reactions typically manifest 24-72 hours after antigen exposure, as seen in tuberculin skin tests.",
                memoryTip: "Type IV = 24-72 hours (delayed)."
            },
            {
                question: "Which cells are primarily involved in Type IV hypersensitivity reactions?",
                options: [
                    "B-lymphocytes and plasma cells",
                    "Mast cells and basophils",
                    "Sensitized T-lymphocytes",
                    "Neutrophils and eosinophils"
                ],
                correct: 2,
                explanation: "Type IV hypersensitivity is mediated by sensitized T-lymphocytes (CD4+ TH1 cells and CD8+ cytotoxic T cells) that recognize antigens and release cytokines or directly kill cells.",
                memoryTip: "Type IV = T-cells (CD4+ TH1, CD8+ CTLs)."
            },
            {
                question: "What is the prototype example of Type IV hypersensitivity?",
                options: [
                    "Bronchial asthma",
                    "Myasthenia gravis",
                    "Tuberculin skin reaction",
                    "Autoimmune hemolytic anemia"
                ],
                correct: 2,
                explanation: "The tuberculin skin test (Mantoux test) is a classic example of Type IV hypersensitivity, where intradermal tuberculin induces a localized delayed reaction in sensitized individuals.",
                memoryTip: "Tuberculin test = Type IV prototype."
            },
            {
                question: "How do cytotoxic T-lymphocytes (CTLs) kill target cells in Type IV hypersensitivity?",
                options: [
                    "By producing IgE antibodies",
                    "By releasing histamine",
                    "Via perforin-granzyme and Fas-FasL pathways",
                    "By forming immune complexes"
                ],
                correct: 2,
                explanation: "CTLs kill target cells through perforin-granzyme dependent killing (pore formation and apoptosis) and Fas-Fas ligand dependent apoptosis.",
                memoryTip: "CTL killing: Perforin-Granzyme & Fas-FasL."
            },
            {
                question: "What is immunologic tolerance?",
                options: [
                    "An exaggerated immune response to antigens",
                    "Lack of immune response to specific antigens",
                    "Autoantibody production against self-tissues",
                    "Deficiency in immune cell production"
                ],
                correct: 1,
                explanation: "Immunologic tolerance is a state where the immune system does not react to specific antigens, crucial for preventing autoimmune responses to self-antigens.",
                memoryTip: "Tolerance = No immune response to specific antigens."
            },
            {
                question: "Central tolerance primarily occurs in:",
                options: [
                    "Peripheral tissues",
                    "Lymph nodes and spleen",
                    "Bone marrow and thymus",
                    "Mucosal surfaces"
                ],
                correct: 2,
                explanation: "Central tolerance occurs in primary lymphoid organs (bone marrow for B-cells, thymus for T-cells), where immature lymphocytes reactive to self-antigens are eliminated (clonal deletion).",
                memoryTip: "Central tolerance = Bone marrow & Thymus (clonal deletion)."
            },
            {
                question: "What mechanism maintains peripheral tolerance by inducing apoptosis of activated T-cells?",
                options: [
                    "Clonal deletion in thymus",
                    "Activation-induced cell death (Fas-FasL)",
                    "Molecular mimicry",
                    "Polyclonal B-cell activation"
                ],
                correct: 1,
                explanation: "Activation-induced cell death via Fas-Fas ligand interaction induces apoptosis of activated T-cells, dampening immune responses and maintaining peripheral tolerance.",
                memoryTip: "Peripheral tolerance: Fas-FasL → T-cell apoptosis."
            },
            {
                question: "Which mechanism can break peripheral T-cell anergy?",
                options: [
                    "Lack of co-stimulatory signals",
                    "Upregulation of B7-1 on APCs",
                    "Defective Fas-FasL signaling",
                    "Clonal deletion in thymus"
                ],
                correct: 1,
                explanation: "Upregulation of co-stimulatory molecules (e.g., B7-1) on antigen-presenting cells provides the second signal needed to activate T-cells, breaking anergy.",
                memoryTip: "Break anergy = B7-1 upregulation on APCs."
            },
            {
                question: "What is autoimmunity?",
                options: [
                    "Immune response against foreign pathogens",
                    "Lack of immune response to infections",
                    "Immune response against self-antigens",
                    "Overactive immune response to allergens"
                ],
                correct: 2,
                explanation: "Autoimmunity is an immune response directed against the body's own tissues (autoantigens), leading to tissue injury and autoimmune diseases.",
                memoryTip: "Autoimmunity = Immune attack on self."
            },
            {
                question: "Which genetic factor is strongly associated with autoimmune diseases?",
                options: [
                    "Blood type O",
                    "HLA class II antigens",
                    "Mitochondrial DNA mutations",
                    "Y chromosome genes"
                ],
                correct: 1,
                explanation: "Certain HLA class II alleles (e.g., HLA-DR, HLA-DQ) are strongly linked to autoimmune diseases like rheumatoid arthritis, type 1 diabetes, and SLE.",
                memoryTip: "Autoimmunity link = HLA class II genes."
            },
            {
                question: "Molecular mimicry refers to:",
                options: [
                    "Similarity between self and microbial antigens",
                    "Identical T-cell receptors on different cells",
                    "Copying of antibody structures",
                    "Mimicking of immune cell functions"
                ],
                correct: 0,
                explanation: "Molecular mimicry occurs when microbial antigens share epitopes with self-antigens, leading to cross-reactive immune responses that attack host tissues.",
                memoryTip: "Molecular mimicry = Microbe resembles self → cross-reaction."
            },
            {
                question: "Which infectious agent is associated with molecular mimicry in rheumatic fever?",
                options: [
                    "Mycobacterium tuberculosis",
                    "Streptococcus pyogenes",
                    "Epstein-Barr virus",
                    "HIV"
                ],
                correct: 1,
                explanation: "Streptococcal M protein shares epitopes with cardiac myosin, leading to cross-reactive antibodies that cause rheumatic heart disease.",
                memoryTip: "Rheumatic fever = Strep M protein mimics cardiac myosin."
            },
            {
                question: "What is the effect of polyclonal B-cell activation in autoimmunity?",
                options: [
                    "Decreases antibody production",
                    "Activates self-reactive B-cells nonspecifically",
                    "Enhances T-cell tolerance",
                    "Prevents autoantibody formation"
                ],
                correct: 1,
                explanation: "Polyclonal B-cell activation by microbes (e.g., EBV, endotoxins) nonspecifically activates B-cells, including those producing autoantibodies, breaking tolerance.",
                memoryTip: "Polyclonal B activation = Nonspecific autoantibody production."
            },
            {
                question: "Release of sequestered antigens can lead to autoimmunity because:",
                options: [
                    "They are recognized as foreign by the immune system",
                    "They suppress immune responses",
                    "They mimic microbial antigens",
                    "They only activate T-cells"
                ],
                correct: 0,
                explanation: "Antigens sequestered from the immune system during development (e.g., lens proteins, sperm) are recognized as foreign if released, triggering autoimmune responses.",
                memoryTip: "Sequestered antigens = Hidden self → foreign if exposed."
            },
            {
                question: "Which autoimmune disease is organ-specific?",
                options: [
                    "Systemic lupus erythematosus",
                    "Hashimoto's thyroiditis",
                    "Rheumatoid arthritis",
                    "Systemic sclerosis"
                ],
                correct: 1,
                explanation: "Hashimoto's thyroiditis is an organ-specific autoimmune disease targeting the thyroid gland, while others listed are systemic (non-organ-specific).",
                memoryTip: "Organ-specific: Hashimoto's (thyroid). Systemic: SLE, RA."
            },
            {
                question: "What is the female-to-male ratio in systemic lupus erythematosus?",
                options: [
                    "1:1",
                    "2:1",
                    "5:1",
                    "9:1"
                ],
                correct: 3,
                explanation: "SLE predominantly affects women of childbearing age, with a female-to-male ratio of approximately 9:1, suggesting hormonal influences.",
                memoryTip: "SLE: Female:Male = 9:1 (hormonal link)."
            },
            {
                question: "Which autoantibody is virtually present in 100% of SLE patients?",
                options: [
                    "Anti-dsDNA",
                    "Anti-Sm",
                    "Antinuclear antibody (ANA)",
                    "Anti-histone"
                ],
                correct: 2,
                explanation: "Antinuclear antibodies (ANA) are sensitive markers found in nearly 100% of SLE patients, though not specific (seen in other autoimmune diseases).",
                memoryTip: "SLE: ANA = 100% sensitive, not specific."
            },
            {
                question: "Which antibody is highly specific for SLE?",
                options: [
                    "ANA",
                    "Anti-dsDNA",
                    "Rheumatoid factor",
                    "Anti-acetylcholine receptor"
                ],
                correct: 1,
                explanation: "Anti-double-stranded DNA (anti-dsDNA) antibodies are highly specific for SLE and correlate with disease activity, especially lupus nephritis.",
                memoryTip: "Anti-dsDNA = Highly specific for SLE."
            },
            {
                question: "What is the most common cause of death in SLE patients?",
                options: [
                    "Skin involvement",
                    "Neuropsychiatric disease",
                    "Renal failure",
                    "Infections"
                ],
                correct: 2,
                explanation: "Renal failure from lupus nephritis is a leading cause of death in SLE, emphasizing the importance of monitoring kidney function.",
                memoryTip: "SLE mortality: Renal failure #1."
            },
            {
                question: "Which hypersensitivity mechanism is primarily involved in SLE tissue injury?",
                options: [
                    "Type I",
                    "Type II",
                    "Type III",
                    "Type IV"
                ],
                correct: 2,
                explanation: "Type III hypersensitivity (immune complex deposition) is the main mechanism in SLE, causing vasculitis, glomerulonephritis, and other visceral lesions.",
                memoryTip: "SLE injury = Type III (immune complexes)."
            },
            {
                question: "What are LE cells?",
                options: [
                    "B-cells producing autoantibodies",
                    "Neutrophils that have phagocytosed denatured nuclei",
                    "Cytotoxic T-cells attacking skin",
                    "Mast cells degranulating in SLE"
                ],
                correct: 1,
                explanation: "LE cells are neutrophils or macrophages that have phagocytosed denatured nuclear material (hematoxylin bodies) opsonized by antinuclear antibodies.",
                memoryTip: "LE cells = Phagocytes with ingested nuclei (SLE)."
            },
            {
                question: "Which renal lesion in SLE has the worst prognosis?",
                options: [
                    "Mesangial glomerulonephritis (Class II)",
                    "Focal proliferative GN (Class III)",
                    "Diffuse proliferative GN (Class IV)",
                    "Membranous GN (Class V)"
                ],
                correct: 2,
                explanation: "Diffuse proliferative glomerulonephritis (Class IV) is the most severe form of lupus nephritis, often leading to renal failure without treatment.",
                memoryTip: "SLE worst kidney: Class IV (Diffuse proliferative GN)."
            },
            {
                question: "What is the characteristic skin rash in SLE?",
                options: [
                    "Palmar erythema",
                    "Butterfly rash on face",
                    "Psoriatic plaques",
                    "Target lesions"
                ],
                correct: 1,
                explanation: "The classic butterfly (malar) rash over the cheeks and nose is characteristic of SLE, often exacerbated by sunlight.",
                memoryTip: "SLE rash = Butterfly (malar) distribution."
            },
            {
                question: "Which cardiovascular manifestation is typical in SLE?",
                options: [
                    "Libman-Sacks endocarditis",
                    "Infective endocarditis",
                    "Rheumatic valvulitis",
                    "Atherosclerosis only"
                ],
                correct: 0,
                explanation: "Libman-Sacks endocarditis is non-bacterial verrucous vegetations on heart valves in SLE, distinct from infective or rheumatic causes.",
                memoryTip: "SLE heart: Libman-Sacks endocarditis (non-bacterial vegetations)."
            },
            {
                question: "Primary immunodeficiency diseases are usually:",
                options: [
                    "Acquired later in life",
                    "Genetically determined",
                    "Caused by infections",
                    "Due to drug toxicity"
                ],
                correct: 1,
                explanation: "Primary immunodeficiencies are inherited (genetic) disorders presenting early in life, affecting development or function of immune components.",
                memoryTip: "Primary immunodeficiency = Genetic, early onset."
            },
            {
                question: "Which primary immunodeficiency affects only B-cells?",
                options: [
                    "DiGeorge syndrome",
                    "Severe combined immunodeficiency (SCID)",
                    "X-linked agammaglobulinemia",
                    "Chronic granulomatous disease"
                ],
                correct: 2,
                explanation: "X-linked agammaglobulinemia (Bruton's) is a B-cell deficiency with absent immunoglobulins, leading to recurrent bacterial infections after maternal antibody wanes.",
                memoryTip: "X-linked agammaglobulinemia = B-cell deficiency (no antibodies)."
            },
            {
                question: "DiGeorge syndrome results from:",
                options: [
                    "Defective NADPH oxidase",
                    "Thymic aplasia",
                    "B-cell maturation arrest",
                    "Complement deficiency"
                ],
                correct: 1,
                explanation: "DiGeorge syndrome is a T-cell deficiency due to thymic aplasia/hypoplasia from abnormal development of third and fourth pharyngeal pouches.",
                memoryTip: "DiGeorge = Thymic aplasia → T-cell deficiency."
            },
            {
                question: "Severe combined immunodeficiency (SCID) involves:",
                options: [
                    "B-cell deficiency only",
                    "T-cell deficiency only",
                    "Both T and B cell deficiencies",
                    "Phagocyte defect only"
                ],
                correct: 2,
                explanation: "SCID is a combined immunodeficiency with severe defects in both T and B lymphocyte development/function, leading to profound susceptibility to infections.",
                memoryTip: "SCID = Severe Combined (T & B cells) Immunodeficiency."
            },
            {
                question: "Secondary immunodeficiencies can result from all EXCEPT:",
                options: [
                    "HIV infection",
                    "Malnutrition",
                    "Chemotherapy",
                    "Genetic mutation at birth"
                ],
                correct: 3,
                explanation: "Genetic mutations at birth cause primary immunodeficiencies. Secondary immunodeficiencies are acquired from infections, malnutrition, drugs, etc.",
                memoryTip: "Secondary = Acquired (HIV, malnutrition, drugs). Primary = Genetic."
            },
            {
                question: "Splenectomy increases susceptibility to infections by:",
                options: [
                    "Viruses only",
                    "Intracellular bacteria",
                    "Encapsulated bacteria",
                    "Fungi only"
                ],
                correct: 2,
                explanation: "Splenectomy impairs clearance of encapsulated bacteria (e.g., Streptococcus pneumoniae, Haemophilus influenzae) due to loss of phagocytic function and IgM production.",
                memoryTip: "Splenectomy → Risk of encapsulated bacteria (pneumococcus)."
            },
            {
                question: "What percentage of the world's HIV infections are in developing countries?",
                options: [
                    "30%",
                    "50%",
                    "70%",
                    "Over 90%"
                ],
                correct: 3,
                explanation: "Over 90% of HIV infections occur in developing countries, with sub-Saharan Africa bearing the greatest burden.",
                memoryTip: "HIV: >90% in developing countries."
            },
            {
                question: "What is the most common mode of HIV transmission worldwide?",
                options: [
                    "Homosexual contact",
                    "Heterosexual contact",
                    "Intravenous drug use",
                    "Mother-to-child"
                ],
                correct: 1,
                explanation: "Heterosexual transmission accounts for approximately 75% of HIV infections globally, especially in Africa.",
                memoryTip: "HIV transmission: Heterosexual #1 worldwide."
            },
            {
                question: "Which cells are the primary targets of HIV?",
                options: [
                    "Red blood cells",
                    "Platelets",
                    "CD4+ T-helper cells",
                    "Neutrophils"
                ],
                correct: 2,
                explanation: "HIV primarily infects CD4+ T-helper cells via binding to CD4 receptor and co-receptors (CCR5 or CXCR4), leading to their depletion.",
                memoryTip: "HIV targets = CD4+ T-cells (helper cells)."
            },
            {
                question: "What is the function of HIV reverse transcriptase?",
                options: [
                    "Integrates viral DNA into host genome",
                    "Converts viral RNA to DNA",
                    "Cleaves viral polyproteins",
                    "Binds to CD4 receptor"
                ],
                correct: 1,
                explanation: "Reverse transcriptase is an RNA-dependent DNA polymerase that converts single-stranded HIV RNA into double-stranded DNA, a key step in viral replication.",
                memoryTip: "Reverse transcriptase = RNA → DNA (unique to retroviruses)."
            },
            {
                question: "Which HIV glycoprotein binds to the CD4 receptor?",
                options: [
                    "gp41",
                    "gp120",
                    "p24",
                    "p17"
                ],
                correct: 1,
                explanation: "gp120 is the surface glycoprotein that binds to CD4 receptors on target cells, initiating viral entry.",
                memoryTip: "gp120 binds CD4; gp41 mediates fusion."
            },
            {
                question: "Macrophage-tropic (M-tropic) HIV strains use which co-receptor?",
                options: [
                    "CXCR4",
                    "CCR5",
                    "CD8",
                    "CD28"
                ],
                correct: 1,
                explanation: "M-tropic HIV strains use CCR5 co-receptor to infect macrophages and primary T-cells. T-tropic strains use CXCR4.",
                memoryTip: "M-tropic = CCR5; T-tropic = CXCR4."
            },
            {
                question: "What is the primary mechanism of CD4+ T-cell loss in HIV infection?",
                options: [
                    "Direct viral cytopathic effect",
                    "Apoptosis of uninfected cells",
                    "Syncytia formation",
                    "All of the above"
                ],
                correct: 3,
                explanation: "Multiple mechanisms contribute: direct viral killing, syncytia formation, apoptosis of uninfected cells (by gp120 binding), and immune-mediated destruction.",
                memoryTip: "CD4 loss = Direct killing + Syncytia + Apoptosis + Immune attack."
            },
            {
                question: "During which phase of HIV infection is viremia highest?",
                options: [
                    "Early acute phase",
                    "Middle chronic phase",
                    "Final crisis phase",
                    "Clinical latency only"
                ],
                correct: 0,
                explanation: "Viremia peaks during the early acute phase (4-8 weeks post-infection), followed by partial control by immune responses and establishment of a viral set point.",
                memoryTip: "Highest viremia = Early acute phase."
            },
            {
                question: "What is the typical CD4+ T-cell count when AIDS is diagnosed?",
                options: [
                    "<200 cells/μL",
                    "200-500 cells/μL",
                    "500-800 cells/μL",
                    ">800 cells/μL"
                ],
                correct: 0,
                explanation: "AIDS is defined by CDC as HIV infection with CD4+ T-cell count <200 cells/μL or occurrence of AIDS-defining illnesses.",
                memoryTip: "AIDS diagnosis: CD4 < 200 cells/μL."
            },
            {
                question: "Which opportunistic infection is common in AIDS patients?",
                options: [
                    "Pneumocystis jirovecii pneumonia",
                    "Streptococcal pharyngitis",
                    "Herpes simplex type 1 (oral)",
                    "Varicella zoster (chickenpox)"
                ],
                correct: 0,
                explanation: "Pneumocystis jirovecii pneumonia (PCP) is a classic opportunistic infection in AIDS patients with low CD4 counts, often the initial AIDS-defining illness.",
                memoryTip: "AIDS: PCP = common opportunistic infection."
            },
            {
                question: "Which malignancy is AIDS-defining?",
                options: [
                    "Basal cell carcinoma",
                    "Kaposi sarcoma",
                    "Colon adenocarcinoma",
                    "Melanoma"
                ],
                correct: 1,
                explanation: "Kaposi sarcoma (associated with HHV-8) is an AIDS-defining malignancy, along with non-Hodgkin lymphoma and cervical carcinoma.",
                memoryTip: "AIDS malignancies: Kaposi sarcoma, NHL, Cervical CA."
            },
            {
                question: "HIV-infected macrophages serve as reservoirs because:",
                options: [
                    "They are resistant to cytopathic effects",
                    "They produce large amounts of virus",
                    "They are easily killed by CD8+ T-cells",
                    "They do not express CD4"
                ],
                correct: 0,
                explanation: "Macrophages are relatively resistant to HIV cytopathic effects, allowing persistent viral production and serving as long-term reservoirs, especially in brain and lungs.",
                memoryTip: "Macrophages = HIV reservoirs (resistant to killing)."
            },
            {
                question: "Which cytokine is pivotal in activating HIV transcription from latent provirus?",
                options: [
                    "IL-4",
                    "IL-10",
                    "TNF-α",
                    "TGF-β"
                ],
                correct: 2,
                explanation: "TNF-α activates NF-κB, which binds to HIV promoter (LTR), enhancing viral transcription and reactivation from latency.",
                memoryTip: "HIV reactivation: TNF-α → NF-κB → viral transcription."
            },
            {
                question: "What is the cause of neurological symptoms in AIDS?",
                options: [
                    "Direct neuronal infection by HIV",
                    "Toxins released by infected macrophages",
                    "Opportunistic CNS infections only",
                    "Both toxins from macrophages and opportunistic infections"
                ],
                correct: 3,
                explanation: "Neurologic damage results from HIV-infected macrophages releasing neurotoxic factors (cytokines, nitric oxide) and opportunistic infections (toxoplasmosis, cryptococcosis).",
                memoryTip: "AIDS dementia: Macrophage toxins + Opportunistic infections."
            },
            {
                question: "Which test is used to monitor HIV disease progression?",
                options: [
                    "Complete blood count",
                    "CD4+ T-cell count and viral load",
                    "Liver function tests",
                    "Serum creatinine"
                ],
                correct: 1,
                explanation: "CD4+ T-cell count (immune status) and HIV RNA viral load (replication activity) are key markers for disease progression and treatment efficacy.",
                memoryTip: "HIV monitoring: CD4 count + Viral load."
            },
            {
                question: "What is the approximate risk of HIV transmission from mother to child without intervention?",
                options: [
                    "5%",
                    "15%",
                    "25-30%",
                    "50%"
                ],
                correct: 2,
                explanation: "Without antiretroviral therapy, 25-30% of HIV-positive mothers transmit the virus to their infants (during pregnancy, delivery, or breastfeeding).",
                memoryTip: "Mother-to-child HIV transmission = 25-30% without treatment."
            },
            {
                question: "Which HIV gene encodes reverse transcriptase?",
                options: [
                    "gag",
                    "pol",
                    "env",
                    "tat"
                ],
                correct: 1,
                explanation: "pol gene encodes viral enzymes: reverse transcriptase, protease, and integrase, essential for replication.",
                memoryTip: "pol = Polymerase (reverse transcriptase), Protease, Integrase."
            },
            {
                question: "What is the role of HIV protease?",
                options: [
                    "Binds to CD4 receptor",
                    "Cleaves viral polyproteins into functional units",
                    "Integrates viral DNA into host genome",
                    "Converts RNA to DNA"
                ],
                correct: 1,
                explanation: "Protease cleaves gag and gag-pol polyproteins into individual functional proteins (e.g., p24, reverse transcriptase) during viral maturation.",
                memoryTip: "HIV protease = Cleaves viral polyproteins (maturation)."
            },
            {
                question: "Which cells are responsible for killing HIV-infected cells?",
                options: [
                    "B-cells",
                    "CD8+ cytotoxic T-lymphocytes",
                    "Neutrophils",
                    "Eosinophils"
                ],
                correct: 1,
                explanation: "CD8+ cytotoxic T-lymphocytes (CTLs) recognize and kill HIV-infected cells, playing a crucial role in controlling viral replication.",
                memoryTip: "Anti-HIV CTLs = CD8+ T-cells."
            },
            {
                question: "What is the primary defect in chronic granulomatous disease?",
                options: [
                    "T-cell deficiency",
                    "B-cell deficiency",
                    "Defective phagocyte oxidative burst",
                    "Complement deficiency"
                ],
                correct: 2,
                explanation: "Chronic granulomatous disease results from defects in NADPH oxidase, impairing phagocyte production of reactive oxygen species needed to kill catalase-positive organisms.",
                memoryTip: "Chronic granulomatous disease = NADPH oxidase defect → no oxidative burst."
            },
            {
                question: "Which complement deficiency increases susceptibility to Neisseria infections?",
                options: [
                    "C1",
                    "C3",
                    "C5-C9 (MAC)",
                    "C4"
                ],
                correct: 2,
                explanation: "Deficiencies in terminal complement components (C5-C9, membrane attack complex) impair lysis of Neisseria bacteria, leading to recurrent meningococcal or gonococcal infections.",
                memoryTip: "Terminal complement deficiency → Neisseria infections."
            },
            {
                question: "In Type I hypersensitivity, which mediator causes bronchospasm and increased mucus?",
                options: [
                    "Histamine",
                    "Prostaglandin D2",
                    "Leukotriene C4",
                    "All of the above"
                ],
                correct: 3,
                explanation: "Histamine, prostaglandin D2, and leukotrienes (C4, D4) all contribute to bronchoconstriction and mucus hypersecretion in asthma.",
                memoryTip: "Asthma mediators: Histamine, PGD2, Leukotrienes → bronchospasm + mucus."
            },
            {
                question: "What is the function of eosinophils in Type I hypersensitivity?",
                options: [
                    "Produce IgE",
                    "Release major basic protein damaging tissues",
                    "Activate complement",
                    "Present antigens to T-cells"
                ],
                correct: 1,
                explanation: "Eosinophils release major basic protein, eosinophil cationic protein, and other toxins that damage tissues, especially in late-phase reactions.",
                memoryTip: "Eosinophils = Tissue damage in late phase (major basic protein)."
            },
            {
                question: "In Type II hypersensitivity, opsonization by C3b leads to:",
                options: [
                    "Direct cell lysis",
                    "Enhanced phagocytosis",
                    "Antibody-dependent cellular cytotoxicity",
                    "Cellular dysfunction"
                ],
                correct: 1,
                explanation: "C3b coats target cells, enhancing phagocytosis via C3b receptors on macrophages and neutrophils (opsonophagocytosis).",
                memoryTip: "C3b = Opsonin → enhances phagocytosis."
            },
            {
                question: "Which disease involves antibodies against acetylcholine receptors?",
                options: [
                    "Myasthenia gravis",
                    "Graves disease",
                    "Pernicious anemia",
                    "Goodpasture syndrome"
                ],
                correct: 0,
                explanation: "Myasthenia gravis is caused by antibodies against acetylcholine receptors at neuromuscular junctions, impairing muscle contraction.",
                memoryTip: "Myasthenia gravis = Anti-ACh receptor antibodies (Type II)."
            },
            {
                question: "Goodpasture syndrome targets which antigen?",
                options: [
                    "Basement membrane collagen (type IV)",
                    "Acetylcholine receptor",
                    "TSH receptor",
                    "Intrinsic factor"
                ],
                correct: 0,
                explanation: "Goodpasture syndrome involves anti-glomerular basement membrane antibodies (against type IV collagen), causing glomerulonephritis and pulmonary hemorrhage.",
                memoryTip: "Goodpasture = Anti-GBM (type IV collagen) → lung/kidney."
            },
            {
                question: "In SLE, antibodies against which nuclear antigen are highly specific?",
                options: [
                    "Sm antigen",
                    "Histones",
                    "SS-A/Ro",
                    "SS-B/La"
                ],
                correct: 0,
                explanation: "Anti-Smith (anti-Sm) antibodies are highly specific for SLE (though less sensitive), directed against small nuclear ribonucleoproteins.",
                memoryTip: "Anti-Sm = Highly specific for SLE."
            }
        ];

        // DOM elements
        const quizContainer = document.getElementById('quiz-container');
        const resultsContainer = document.getElementById('results-container');
        const questionNumber = document.getElementById('question-number');
        const questionText = document.getElementById('question-text');
        const optionsContainer = document.getElementById('options-container');
        const explanationContainer = document.getElementById('explanation-container');
        const explanationText = document.getElementById('explanation-text');
        const memoryTipText = document.getElementById('memory-tip-text');
        const prevBtn = document.getElementById('prev-btn');
        const nextBtn = document.getElementById('next-btn');
        const submitBtn = document.getElementById('submit-btn');
        const progressFill = document.getElementById('progress-fill');
        const progressText = document.getElementById('progress-text');
        const timeDisplay = document.getElementById('time');
        const scoreDisplay = document.getElementById('score');
        const scoreText = document.getElementById('score-text');
        const totalQuestions = document.getElementById('total-questions');
        const correctAnswers = document.getElementById('correct-answers');
        const incorrectAnswers = document.getElementById('incorrect-answers');
        const percentage = document.getElementById('percentage');
        const timeTaken = document.getElementById('time-taken');
        const questionReview = document.getElementById('question-review');
        const restartBtn = document.getElementById('restart-btn');

        // Quiz state
        let currentQuestion = 0;
        let userAnswers = new Array(questions.length).fill(null);
        let score = 0;
        let timer;
        let timeLeft = 65 * 60; // 65 minutes in seconds
        let quizCompleted = false;

        // Initialize quiz
        function initQuiz() {
            displayQuestion();
            startTimer();
            updateProgress();
        }

        // Display current question
        function displayQuestion() {
            const question = questions[currentQuestion];
            questionNumber.textContent = `Question ${currentQuestion + 1} of ${questions.length}`;
            questionText.textContent = question.question;
            
            optionsContainer.innerHTML = '';
            question.options.forEach((option, index) => {
                const optionElement = document.createElement('div');
                optionElement.className = 'option';
                if (userAnswers[currentQuestion] === index) {
                    optionElement.classList.add('selected');
                }
                optionElement.textContent = option;
                optionElement.addEventListener('click', () => selectOption(index));
                optionsContainer.appendChild(optionElement);
            });
            
            // Show/hide explanation
            if (userAnswers[currentQuestion] !== null) {
                showExplanation();
            } else {
                explanationContainer.style.display = 'none';
            }
            
            // Update button states
            prevBtn.disabled = currentQuestion === 0;
            nextBtn.disabled = false;
            submitBtn.style.display = currentQuestion === questions.length - 1 ? 'block' : 'none';
        }

        // Select an option
        function selectOption(index) {
            if (quizCompleted) return;
            
            userAnswers[currentQuestion] = index;
            
            // Update UI
            const options = document.querySelectorAll('.option');
            options.forEach(option => option.classList.remove('selected'));
            options[index].classList.add('selected');
            
            showExplanation();
        }

        // Show explanation for current question
        function showExplanation() {
            const question = questions[currentQuestion];
            explanationText.textContent = question.explanation;
            memoryTipText.textContent = question.memoryTip;
            explanationContainer.style.display = 'block';
            
            // Highlight correct/incorrect answers
            const options = document.querySelectorAll('.option');
            options.forEach((option, index) => {
                option.classList.remove('correct', 'incorrect');
                if (index === question.correct) {
                    option.classList.add('correct');
                } else if (index === userAnswers[currentQuestion] && index !== question.correct) {
                    option.classList.add('incorrect');
                }
            });
        }

        // Navigate to next question
        function nextQuestion() {
            if (currentQuestion < questions.length - 1) {
                currentQuestion++;
                displayQuestion();
                updateProgress();
            }
        }

        // Navigate to previous question
        function prevQuestion() {
            if (currentQuestion > 0) {
                currentQuestion--;
                displayQuestion();
                updateProgress();
            }
        }

        // Update progress bar
        function updateProgress() {
            const progress = ((currentQuestion + 1) / questions.length) * 100;
            progressFill.style.width = `${progress}%`;
            progressText.textContent = `${currentQuestion + 1}/${questions.length}`;
        }

        // Start timer
        function startTimer() {
            timer = setInterval(() => {
                timeLeft--;
                
                const minutes = Math.floor(timeLeft / 60);
                const seconds = timeLeft % 60;
                timeDisplay.textContent = `${minutes.toString().padStart(2, '0')}:${seconds.toString().padStart(2, '0')}`;
                
                if (timeLeft <= 0) {
                    clearInterval(timer);
                    submitQuiz();
                }
            }, 1000);
        }

        // Submit quiz
        function submitQuiz() {
            clearInterval(timer);
            quizCompleted = true;
            
            // Calculate score
            score = 0;
            for (let i = 0; i < questions.length; i++) {
                if (userAnswers[i] === questions[i].correct) {
                    score++;
                }
            }
            
            // Display results
            quizContainer.style.display = 'none';
            resultsContainer.style.display = 'block';
            
            scoreDisplay.textContent = `${score}/${questions.length}`;
            totalQuestions.textContent = questions.length;
            correctAnswers.textContent = score;
            incorrectAnswers.textContent = questions.length - score;
            percentage.textContent = `${((score / questions.length) * 100).toFixed(1)}%`;
            
            const minutesTaken = Math.floor((65 * 60 - timeLeft) / 60);
            const secondsTaken = (65 * 60 - timeLeft) % 60;
            timeTaken.textContent = `${minutesTaken.toString().padStart(2, '0')}:${secondsTaken.toString().padStart(2, '0')}`;
            
            // Set score text
            if (score >= questions.length * 0.8) {
                scoreText.textContent = "Excellent! You have mastered Immunopathology (Chapter 7).";
            } else if (score >= questions.length * 0.6) {
                scoreText.textContent = "Good job! You have a solid understanding of Immunopathology.";
            } else if (score >= questions.length * 0.5) {
                scoreText.textContent = "You passed! Review the explanations to strengthen your knowledge.";
            } else {
                scoreText.textContent = "You need more study. Review Chapter 7 material and try again.";
            }
            
            // Generate question review
            generateQuestionReview();
        }

        // Generate question review
        function generateQuestionReview() {
            questionReview.innerHTML = '<h3>Question Review</h3>';
            
            questions.forEach((question, index) => {
                const reviewItem = document.createElement('div');
                reviewItem.className = 'review-item';
                
                const reviewQuestion = document.createElement('div');
                reviewQuestion.className = 'review-question';
                reviewQuestion.textContent = `${index + 1}. ${question.question}`;
                
                const userAnswer = document.createElement('div');
                userAnswer.className = 'review-answer';
                if (userAnswers[index] !== null) {
                    userAnswer.innerHTML = `Your answer: <span class="user-answer">${question.options[userAnswers[index]]}</span>`;
                } else {
                    userAnswer.innerHTML = `Your answer: <span class="user-answer">Not answered</span>`;
                }
                
                const correctAnswer = document.createElement('div');
                correctAnswer.className = 'review-answer';
                correctAnswer.innerHTML = `Correct answer: <span class="correct-answer">${question.options[question.correct]}</span>`;
                
                reviewItem.appendChild(reviewQuestion);
                reviewItem.appendChild(userAnswer);
                reviewItem.appendChild(correctAnswer);
                
                questionReview.appendChild(reviewItem);
            });
        }

        // Restart quiz
        function restartQuiz() {
            currentQuestion = 0;
            userAnswers = new Array(questions.length).fill(null);
            score = 0;
            timeLeft = 65 * 60;
            quizCompleted = false;
            
            quizContainer.style.display = 'block';
            resultsContainer.style.display = 'none';
            
            initQuiz();
        }

        // Event listeners
        prevBtn.addEventListener('click', prevQuestion);
        nextBtn.addEventListener('click', nextQuestion);
        submitBtn.addEventListener('click', submitQuiz);
        restartBtn.addEventListener('click', restartQuiz);

        // Start the quiz
        initQuiz();
    </script>
</body>
        </html>
